Investment Details
Investor Type
Hedge Fund
Asset Class Focus
Equity, Debt, Alternative Investments
Stage Focus
Growth, Late Stage, Pre-IPO, Buyout, Turnaround, Distressed
Geographical Focus
United States, United Kingdom, Cayman Islands
Industries Focus
- Technology
- Healthcare
- Energy
- Shipping
- Biotech
- Financials
- Structured Finance
- Opportunistic
- Litigation
Investment Size:
5,000,000 to 100,000,000 USD
Investor Details Founded: 2004
QVT Fund is a hedge fund specializing in diverse investment strategies across multiple asset classes and industries.
The firm focuses on equity, debt, and alternative investments, targeting stages from growth to distressed opportunities. Its geographical focus includes the United States, United Kingdom, and the Cayman Islands.
QVT Fund's portfolio spans sectors such as biotech, healthcare, technology, energy, shipping, financials, structured finance, opportunistic investments, and litigation. The firm typically invests between $5 million and $100 million per opportunity.
Requirements
- Open to accredited investors
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- GridPoint
- Lightsynq Technologies
- Active Surfaces
- Kriya Therapeutics
- AveXis
- REGENXBIO
- Ocera Therapeutics
- Acceleron Pharma
- Resolvyx Pharmaceuticals
- Concert Pharmaceuticals
Claim this Investor
Are you an official representative of QVT Fund?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim